Lunit and CellCarta Forge Alliance to Enhance AI-Driven Digital Pathology in Biopharma Lunit and CellCarta have joined forces to accelerate AI-enabled digital pathology workflows, enhancing companion diagnostics in biopharma.

Lunit and CellCarta Forge Alliance to Enhance AI-Driven Digital Pathology in Biopharma #South_Korea #Seoul #Lunit #CellCarta #AI_Pathology

HistoIndex and Houston Research Institute Join Forces to Enhance MASH Diagnostics HistoIndex has formed a strategic alliance with Houston Research Institute to enhance diagnostic services for patients with MASH, leveraging AI technology.

HistoIndex and Houston Research Institute Join Forces to Enhance MASH Diagnostics #USA #Houston #MASH #HistoIndex #AI_Pathology

Growth Prospects of the Global AI-Powered Pathology Market Until 2030 Explore the projected expansion of the global AI-powered pathology market, poised for significant growth driven by technological advancements and increased efficiency in diagnostics.

Growth Prospects of the Global AI-Powered Pathology Market Until 2030 #India #healthcare_technology #Bangalore #Valuates_Reports #AI_Pathology

Medmain's PidPort Cloud System Begins Trials at Vietnam's Ha Dong General Hospital Medmain's digital pathology AI system, PidPort, has started its trials at Ha Dong General Hospital in Hanoi, Vietnam, enhancing diagnostic accuracy.

Medmain's PidPort Cloud System Begins Trials at Vietnam's Ha Dong General Hospital #Vietnam #Hanoi #AI_Pathology #Medmain #PidPort

Medmain and SMC Form Strategic Partnership for AI Pathology in Vietnam Medmain Inc. and SMC Medical Tourism Japan have signed a partnership to promote AI-driven pathology diagnostics in Vietnam, enhancing medical cooperation.

Medmain and SMC Form Strategic Partnership for AI Pathology in Vietnam #Japan #Fukuoka #SMC #AI_Pathology #Medmain

Gestalt Diagnostics Secures $7.5 Million in Series A Funding to Enhance AI-Driven Pathology Solutions Gestalt Diagnostics has successfully closed a $7.5 million Series A funding round to enhance their AI-powered pathology platform, PathFlow, improving diagnostic capabilities.

Gestalt Diagnostics Secures $7.5 Million in Series A Funding to Enhance AI-Driven Pathology Solutions #USA #Spokane #AI_Pathology #Gestalt_Diagnostics #PathFlow

Aignostics Unveils Breakthrough Pathology Foundation Model Developed with Mayo Clinic Aignostics introduces a cutting-edge pathology foundation model, developed in collaboration with Mayo Clinic, enhancing diagnosis efficiency.

Aignostics Unveils Breakthrough Pathology Foundation Model Developed with Mayo Clinic #Germany #Berlin #Mayo_Clinic #Aignostics #AI_Pathology